A Phase 3, Multi-center, Randomized Study Evaluating Efficacy of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-Invasive Urothelial Carcinoma (M

Administered By

Awarded By

Contributors

Start/End

  • August 9, 2021 - July 31, 2028